Vowst™ (fecal microbiota spores live-brpk)
| Full Name | Vowst™ (fecal microbiota spores live-brpk) |
| Drug | Vowst |
| Manufacturer | Aimmune Therapeutics |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | Prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI) |
| Disease | Recurrent C. difficile Infection (rCDI) |
| Therapeutic Area | Infectious Disease; Gastroenterology |
| Enrollment Form Link | Vowst Enrollment Form |
| Phone Number | 800-485-4885 |
| Fax Number | 877-640-5179 |
| Product Website | vowsthcp.com |